BINX HEALTH, LTD.
1 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (1)
Devices registered here (4)
- Instrumentation For Clinical Multiplex Test SystemsProduct code NSU (opens in a new tab) · Class II · Clinical Chemistry · 21 CFR 862.2570
- Dna Probe, Nucleic Acid Amplification, ChlamydiaProduct code MKZ (opens in a new tab) · Class I · Microbiology · 21 CFR 866.3120
- Dna-Reagents, NeisseriaProduct code LSL (opens in a new tab) · Class II · Microbiology · 21 CFR 866.3390
- Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted InfectionsProduct code QEP (opens in a new tab) · Class II · Microbiology · 21 CFR 866.3393
Recalls & enforcement
- Class IIOngoing2023-03-29May not meet the declared performance characteristics for the detection of Chlamydia trachomatis (CT) within the labeled expiry period, potential to produce either false negative CT or positive CT results
Related
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “BINX HEALTH, LTD. (FEI 3017907743) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3017907743-binx-health-ltd/
Alerts for BINX HEALTH, LTD.
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.